Central Laboratories Applications & Studies

1. Effect Of Etrasimod On Immune Cell Subsets In Colonic Tissue 9/25/2025

   Etrasimod selectively modulates S1P receptors to reduce inflammation and immune cell trafficking to the gut, showing promise in treating moderate to severe ulcerative colitis.

2. Streamlining Global Respiratory Trial Complexities With Robust Data Capture Strategy 9/23/2025

   Want to see how eCOA solutions can simplify patient-reported data capture and accelerate global trials? Explore implementation strategies, lessons learned, and measurable results.

3. Revitalizing Recruitment In A Lupus Rescue Study 9/11/2025
4. Removing Translation Bottlenecks With AI 8/8/2025

   See how an AI-enabled approach eliminated the manual, time-consuming translation bottlenecks that often delay clinical trial launches.

    

5. Flexible Data Management For Growing Portfolio 7/31/2025

   Explore strategic enhancements to a small biopharma's biometrics capabilities involving the deployment of 20 specialized professionals, which effectively bolstered the client’s organizational capacity.

6. Analytics–Powered Approach To Patient Recruitment Strategy 7/15/2025

   In a Phase 3 psychiatry trial, a pharmaceutical company partnered with Signant to revolutionize patient recruitment through data-driven site selection using PureSignal Analytics.

7. Reframing Clinical Vendor Selection 7/2/2025

   Explore a platform that enables seamless vendor selection as well as cross-functional collaboration with built-in templates and tailored question libraries that simplify proposal creation and review.

8. Pioneering Cancer Research Meets Unparalleled Veeva Vault Integration 6/26/2025

   A biotech company revolutionizing cancer treatment faced delays due to a complex, error-prone document review process. Discover how integrating an innovative strategy transformed their workflow.

9. RWD's Significance In The Largest FDA-Funded IOL Study Of Pediatric Patients 5/28/2025

   With FDA grant support, the American Academy of Ophthalmology and Verana Health conducted the largest real-world study to date on intraocular lens (IOL) use in pediatric cataract patients.

10. Understanding Real-World Patient Characterization And Safety Outcomes Of DEXTENZA 5/8/2025

    In this study, we can derive confirmation of DEXTENZA’s favorable safety profile across a broader surgical spectrum.